IWP
RANI icon

IAG Wealth Partners’s Rani Therapeutics RANI Stock Holding History

IAG Wealth Partners’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,005
Closed -$3.34K – 457
2023
Q4 		$3.34K Hold
1,005
– – ﹤0.01% 375
2023
Q3 		$2.19K Hold
1,005
– – ﹤0.01% 395
2023
Q2 		$4.14K Buy
+1,005
New +$4.67K ﹤0.01% 380

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAG Wealth Partners's RANI Position: Q1 2024 in Review

IAG Wealth Partners sold out of Rani Therapeutics (RANI) in Q1 2024, closing a stake of 1,005 shares — an estimated $3.34K sold.

IAG Wealth Partners first reported a position in RANI in Q2 2023 and held it in 3 quarters. The position peaked at $4.14K in Q2 2023. 37 funds tracked by Wall St. Rank hold RANI as of Q1 2024.

  • IAG Wealth Partners reported no remaining Rani Therapeutics position as of Q1 2024 after selling out during the quarter.
  • IAG Wealth Partners sold 1,005 Rani Therapeutics shares in Q1 2024, an estimated $3.34K.
  • IAG Wealth Partners first reported a position in Rani Therapeutics in Q2 2023 and held it in 3 quarters.
  • IAG Wealth Partners's Rani Therapeutics position peaked at $4.14K in Q2 2023.
  • 37 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2024.

Based on IAG Wealth Partners's 13F filing for Q1 2024, filed 24 Apr 2024.